MedEquities Realty Trust (MRT) Receiving Favorable Media Coverage, Study Finds

News coverage about MedEquities Realty Trust (NYSE:MRT) has trended positive on Saturday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. MedEquities Realty Trust earned a news impact score of 0.30 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 44.9456459870355 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

MedEquities Realty Trust (NYSE MRT) opened at $10.91 on Friday. The firm has a market capitalization of $345.82, a price-to-earnings ratio of 9.90 and a beta of -0.75. MedEquities Realty Trust has a 52-week low of $10.06 and a 52-week high of $13.06.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 29th. Investors of record on Wednesday, November 15th were given a dividend of $0.21 per share. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.84 annualized dividend and a yield of 7.70%. MedEquities Realty Trust’s dividend payout ratio (DPR) is presently 210.01%.

MRT has been the topic of a number of research reports. ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. KeyCorp reiterated a “buy” rating and set a $13.00 target price on shares of MedEquities Realty Trust in a research report on Friday, August 25th. B. Riley reiterated a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 8th. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price on the stock in a research report on Wednesday, November 15th. Finally, Capital One Financial began coverage on MedEquities Realty Trust in a research report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $12.83.

In related news, CEO John W. Mcroberts bought 18,000 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were bought at an average cost of $10.74 per share, for a total transaction of $193,320.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Randy L. Churchey bought 5,300 shares of the stock in a transaction that occurred on Monday, November 20th. The shares were bought at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the completion of the transaction, the director now directly owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The disclosure for this purchase can be found here. Insiders have purchased 23,600 shares of company stock worth $254,129 over the last quarter. 2.50% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “MedEquities Realty Trust (MRT) Receiving Favorable Media Coverage, Study Finds” was reported by Week Herald and is owned by of Week Herald. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://weekherald.com/2017/12/09/medequities-realty-trust-mrt-receiving-favorable-media-coverage-study-finds.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply